Widely read:
The Board has recommended dividend @ 250% i.e. Rs. 2.5/- per share (face value of Re. 1/-) on the equity shares of the Company for FY 2023-24 subject to approval of the shareholders at the ensuing Annual General Meeting.
24-May-2024 Glenmark Pharmaceuticals
The Board has recommended dividend @ 250% i.e. Rs. 2.5/- per share (face value of Re. 1/-) on the equity shares of the Company for FY 2023-24 subject to approval of the shareholders at the ensuing Annual General Meeting.
16 min read•By Value Research
3 min read•By Dhirendra Kumar
4 min read•By Value Research
Please subscribe to Value Research Premium to unlock the custom duration feature and enhance your experience.
Recommendations for the best investments and allocations that are most optimal for your goal
Backed by research by a team of investment experts with over 30 years of experience
Continuous analysis and support from our team to make sure your goals stay on track
